The development of RA is a multistep process in which early phases are characterized by the presence of genetic and environmental risk factors and the systemic autoimmunity associated with RA, such as rheumatoid factor (RF) and anticitrullinated protein antibodies (ACPA) [2]. The gene discussed is PRTN3; the disease is rheumatoid arthritis.